PSYCHOPHARMACOLOGY, ISSN 0033-3158, 07/2011, Volume 216, Issue 2, pp. 173 - 186
Adenosine A(2A) antagonists can reverse many of the behavioral effects of dopamine antagonists, including actions on instrumental behavior. However, little is...
Dopamine | RECEPTOR ANTAGONISTS | PSYCHIATRY | CAFFEINE | Depression | Activation | Anergia | SCHEDULE-CONTROLLED BEHAVIOR | NEUROSCIENCES | NUCLEUS-ACCUMBENS | Parkinsonism | SYMPATHOMIMETIC AMINES | LOCOMOTOR SUPPRESSION | DECISION-MAKING | Psychomotor slowing | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | MSX-3 REVERSES | Adenosine | Analysis | Theophylline | Caffeine
Dopamine | RECEPTOR ANTAGONISTS | PSYCHIATRY | CAFFEINE | Depression | Activation | Anergia | SCHEDULE-CONTROLLED BEHAVIOR | NEUROSCIENCES | NUCLEUS-ACCUMBENS | Parkinsonism | SYMPATHOMIMETIC AMINES | LOCOMOTOR SUPPRESSION | DECISION-MAKING | Psychomotor slowing | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | MSX-3 REVERSES | Adenosine | Analysis | Theophylline | Caffeine
Journal Article
Behavioural Pharmacology, ISSN 0955-8810, 06/2019, Volume 30, Issue 4, pp. 327 - 334
Most studies on discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) have been conducted using a relatively low dose (1.5 mg/kg), and...
4-methylenedioxymethamphetamine | MEDIATION | rat | (+)-AMPHETAMINE | amphetamine | COCAINE | DEPLETION | NEUROSCIENCES | serotonin | RECEPTOR SUBTYPES | drug discrimination | RITANSERIN | 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | dopamine
4-methylenedioxymethamphetamine | MEDIATION | rat | (+)-AMPHETAMINE | amphetamine | COCAINE | DEPLETION | NEUROSCIENCES | serotonin | RECEPTOR SUBTYPES | drug discrimination | RITANSERIN | 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | dopamine
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2013, Volume 73, Issue 8, pp. 729 - 737
Background Recent evidence implicates toll-like receptor 4 (TLR4) in opioid analgesia, tolerance, conditioned place preference, and self-administration. Here,...
Psychiatry | extinction | reinstatement | relapse | Craving | opioid drugs | glia | heroin self-administration | TLR4 | DRUG-DEPENDENCE | CONDITIONED IMMUNOMODULATION | PSYCHIATRY | COCAINE-SEEKING | DOPAMINE D-1-FAMILY RECEPTORS | FACTOR-KAPPA-B | NEUROSCIENCES | VENTRAL TEGMENTAL AREA | NUCLEUS-ACCUMBENS | STRESS-INDUCED REINSTATEMENT | TIME-DEPENDENT CHANGES | CENTRAL-NERVOUS-SYSTEM | Behavior, Addictive - drug therapy | Cues | Naltrexone - therapeutic use | Drug Administration Schedule | Stereoisomerism | Extinction, Psychological - drug effects | Rats | Dose-Response Relationship, Drug | Naltrexone - pharmacology | Self Administration | Animals | Conditioning, Operant - drug effects | Narcotic Antagonists - therapeutic use | Time Factors | Methamphetamine - administration & dosage | Narcotic Antagonists - pharmacology | Heroin - administration & dosage | Toll-Like Receptor 4 - antagonists & inhibitors | Infusion Pumps, Implantable - psychology | Naltrexone - administration & dosage | Physiological aspects | Naltrexone | Heroin | craving
Psychiatry | extinction | reinstatement | relapse | Craving | opioid drugs | glia | heroin self-administration | TLR4 | DRUG-DEPENDENCE | CONDITIONED IMMUNOMODULATION | PSYCHIATRY | COCAINE-SEEKING | DOPAMINE D-1-FAMILY RECEPTORS | FACTOR-KAPPA-B | NEUROSCIENCES | VENTRAL TEGMENTAL AREA | NUCLEUS-ACCUMBENS | STRESS-INDUCED REINSTATEMENT | TIME-DEPENDENT CHANGES | CENTRAL-NERVOUS-SYSTEM | Behavior, Addictive - drug therapy | Cues | Naltrexone - therapeutic use | Drug Administration Schedule | Stereoisomerism | Extinction, Psychological - drug effects | Rats | Dose-Response Relationship, Drug | Naltrexone - pharmacology | Self Administration | Animals | Conditioning, Operant - drug effects | Narcotic Antagonists - therapeutic use | Time Factors | Methamphetamine - administration & dosage | Narcotic Antagonists - pharmacology | Heroin - administration & dosage | Toll-Like Receptor 4 - antagonists & inhibitors | Infusion Pumps, Implantable - psychology | Naltrexone - administration & dosage | Physiological aspects | Naltrexone | Heroin | craving
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 04/2003, Volume 305, Issue 1, pp. 323 - 330
We showed previously that cAMP response element-binding protein (CREB) within the nucleus accumbens (NAc) of rats regulates immobility in the forced swim test...
DEPRESSION | STIMULATION | SENSITIZATION | DRUGS | COCAINE WITHDRAWAL | DOPAMINE | PHARMACOLOGY & PHARMACY | NUCLEUS-ACCUMBENS SHELL | BRAIN REWARD PATHWAYS | AMPHETAMINE | 5'-GUANIDINONALTRINDOLE | Receptors, Opioid, kappa - antagonists & inhibitors | Animals | Narcotic Antagonists - pharmacology | Motor Activity - drug effects | Rats | Male | Models, Animal | Antidepressive Agents - pharmacology | Swimming | Rats, Sprague-Dawley
DEPRESSION | STIMULATION | SENSITIZATION | DRUGS | COCAINE WITHDRAWAL | DOPAMINE | PHARMACOLOGY & PHARMACY | NUCLEUS-ACCUMBENS SHELL | BRAIN REWARD PATHWAYS | AMPHETAMINE | 5'-GUANIDINONALTRINDOLE | Receptors, Opioid, kappa - antagonists & inhibitors | Animals | Narcotic Antagonists - pharmacology | Motor Activity - drug effects | Rats | Male | Models, Animal | Antidepressive Agents - pharmacology | Swimming | Rats, Sprague-Dawley
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2008, Volume 63, Issue 8, pp. 730 - 735
Background Single subanesthetic doses of ketamine, a non-competitive NMDA receptor (NMDAr) antagonist, induce cognitive impairment, schizophreniform psychosis,...
Psychiatry | electrocorticogram | neural synchrony | d-amphetamine | schizophrenia | Apomorphine | glutamate | Dopamine Agonists - pharmacology | Receptors, N-Methyl-D-Aspartate - drug effects | Wakefulness - drug effects | Dextroamphetamine - pharmacology | Dopamine Uptake Inhibitors - pharmacology | Rats, Wistar | Rats | Male | Excitatory Amino Acid Antagonists - pharmacology | Nerve Net - drug effects | Arousal - drug effects | Cortical Synchronization | Neocortex - drug effects | Animals | Apomorphine - pharmacology | Electroencephalography - drug effects | Injections, Subcutaneous | Synaptic Transmission - drug effects | Dizocilpine Maleate - pharmacology | Ketamine - pharmacology | Life Sciences | Human health and pathology | Neurons and Cognition | Psychiatrics and mental health
Psychiatry | electrocorticogram | neural synchrony | d-amphetamine | schizophrenia | Apomorphine | glutamate | Dopamine Agonists - pharmacology | Receptors, N-Methyl-D-Aspartate - drug effects | Wakefulness - drug effects | Dextroamphetamine - pharmacology | Dopamine Uptake Inhibitors - pharmacology | Rats, Wistar | Rats | Male | Excitatory Amino Acid Antagonists - pharmacology | Nerve Net - drug effects | Arousal - drug effects | Cortical Synchronization | Neocortex - drug effects | Animals | Apomorphine - pharmacology | Electroencephalography - drug effects | Injections, Subcutaneous | Synaptic Transmission - drug effects | Dizocilpine Maleate - pharmacology | Ketamine - pharmacology | Life Sciences | Human health and pathology | Neurons and Cognition | Psychiatrics and mental health
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 09/2017, Volume 334, pp. 61 - 71
Brain injury, including that due to stroke, leaves individuals with cognitive deficits that can disrupt daily aspect of living. As of now there are few...
Recovery of function | Amphetamine | Noradrenaline | Brain injury | MEDIAL AGRANULAR CORTEX | BRAIN-INJURY | NEUROTROPHIC FACTOR | FIBROBLAST-GROWTH-FACTOR | UNILATERAL LESIONS | NEUROSCIENCES | VAGUS NERVE-STIMULATION | BEHAVIORAL RECOVERY | POSTERIOR PARIETAL CORTEX | DORSOMEDIAL PREFRONTAL CORTEX | BEHAVIORAL SCIENCES | MOTOR RECOVERY | Brain | Analysis | Therapeutics | Central nervous system agents | Injuries | Homeopathy | Materia medica and therapeutics
Recovery of function | Amphetamine | Noradrenaline | Brain injury | MEDIAL AGRANULAR CORTEX | BRAIN-INJURY | NEUROTROPHIC FACTOR | FIBROBLAST-GROWTH-FACTOR | UNILATERAL LESIONS | NEUROSCIENCES | VAGUS NERVE-STIMULATION | BEHAVIORAL RECOVERY | POSTERIOR PARIETAL CORTEX | DORSOMEDIAL PREFRONTAL CORTEX | BEHAVIORAL SCIENCES | MOTOR RECOVERY | Brain | Analysis | Therapeutics | Central nervous system agents | Injuries | Homeopathy | Materia medica and therapeutics
Journal Article
Addiction Biology, ISSN 1355-6215, 11/2013, Volume 18, Issue 6, pp. 912 - 920
ABSTRACT Evidence suggests that acute exposure to (+/‐)3,4‐methylenedioxymethamphetamine (MDMA) produces qualitatively similar effects on recognition task...
Cocaine | memory | delayed matching to sample | dopamine | MDMA | PROACTIVE-INTERFERENCE | COGNITIVE PERFORMANCE | DOPAMINE RELEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | RATS | SUBSTANCE ABUSE | SHORT-TERM-MEMORY | PREFRONTAL CORTEX | RECEPTOR ANTAGONIST | ECSTASY MDMA | D-AMPHETAMINE | WORKING-MEMORY | Receptors, Dopamine D1 - antagonists & inhibitors | Neurotransmitter Uptake Inhibitors - adverse effects | Neurotransmitter Uptake Inhibitors - antagonists & inhibitors | Humans | N-Methyl-3,4-methylenedioxyamphetamine - adverse effects | Injections, Intraperitoneal | Rats | Male | Psychomotor Performance - drug effects | Benzazepines - pharmacology | Animals | Recognition (Psychology) - drug effects | Analysis of Variance | Time Factors | Dopamine Antagonists - pharmacology | N-Methyl-3,4-methylenedioxyamphetamine - antagonists & inhibitors | Cocaine - adverse effects | Dopamine D2 Receptor Antagonists | Salicylamides - pharmacology | Cocaine - antagonists & inhibitors | Memory | Analysis | Ecstasy (Drug) | Resveratrol | Addiction
Cocaine | memory | delayed matching to sample | dopamine | MDMA | PROACTIVE-INTERFERENCE | COGNITIVE PERFORMANCE | DOPAMINE RELEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | RATS | SUBSTANCE ABUSE | SHORT-TERM-MEMORY | PREFRONTAL CORTEX | RECEPTOR ANTAGONIST | ECSTASY MDMA | D-AMPHETAMINE | WORKING-MEMORY | Receptors, Dopamine D1 - antagonists & inhibitors | Neurotransmitter Uptake Inhibitors - adverse effects | Neurotransmitter Uptake Inhibitors - antagonists & inhibitors | Humans | N-Methyl-3,4-methylenedioxyamphetamine - adverse effects | Injections, Intraperitoneal | Rats | Male | Psychomotor Performance - drug effects | Benzazepines - pharmacology | Animals | Recognition (Psychology) - drug effects | Analysis of Variance | Time Factors | Dopamine Antagonists - pharmacology | N-Methyl-3,4-methylenedioxyamphetamine - antagonists & inhibitors | Cocaine - adverse effects | Dopamine D2 Receptor Antagonists | Salicylamides - pharmacology | Cocaine - antagonists & inhibitors | Memory | Analysis | Ecstasy (Drug) | Resveratrol | Addiction
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 8/2019, Volume 33, Issue 8, pp. 1015 - 1029
Background: The functional role of dopamine D1 and D2 receptors in gambling disorder (GD) remains unclear. Aims: This study aimed to investigate the role of D1...
amphetamine | impulsivity | Gambling | dopamine | DRUG | HALOPERIDOL | PSYCHIATRY | BEHAVIORAL SENSITIZATION | LOCOMOTOR-ACTIVITY | RECEPTOR | PATHOLOGICAL GAMBLERS | REWARD | NEUROSCIENCES | CLINICAL NEUROLOGY | NUCLEUS-ACCUMBENS | PHARMACOLOGY & PHARMACY | SUBJECTIVE RESPONSES | D-AMPHETAMINE | Impulsivity | Dopamine | Activation | Antagonists | Haloperidol | Receptors | Dopamine D1 receptors | Fluphenazine | Amphetamine | Salience | Games | Legalized gambling | Impulsive behavior | Dopamine D2 receptors | Gaming machines
amphetamine | impulsivity | Gambling | dopamine | DRUG | HALOPERIDOL | PSYCHIATRY | BEHAVIORAL SENSITIZATION | LOCOMOTOR-ACTIVITY | RECEPTOR | PATHOLOGICAL GAMBLERS | REWARD | NEUROSCIENCES | CLINICAL NEUROLOGY | NUCLEUS-ACCUMBENS | PHARMACOLOGY & PHARMACY | SUBJECTIVE RESPONSES | D-AMPHETAMINE | Impulsivity | Dopamine | Activation | Antagonists | Haloperidol | Receptors | Dopamine D1 receptors | Fluphenazine | Amphetamine | Salience | Games | Legalized gambling | Impulsive behavior | Dopamine D2 receptors | Gaming machines
Journal Article
Neuroscience, ISSN 0306-4522, 2009, Volume 158, Issue 2, pp. 705 - 712
Abstract Introduction: Electrophysiological responses to auditory stimuli have provided a useful means of elucidating mechanisms and evaluating treatments in...
Neurology | NMDA | electroencephalography | frequency oscillations | animal model | RAT | PREPULSE INHIBITION | NETWORKS | GAMMA-OSCILLATIONS | NEUROSCIENCES | MISMATCH NEGATIVITY | KETAMINE | IN-VITRO | AUDITORY-EVOKED POTENTIALS | DOPAMINE | ACOUSTIC STARTLE | Schizophrenia - chemically induced | Evoked Potentials, Auditory - drug effects | Mice, Inbred C57BL | Risperidone - pharmacology | Amphetamine - administration & dosage | Male | Electroencephalography | Biological Clocks - drug effects | Acoustic Stimulation - methods | Ketamine - adverse effects | Animals | Drug Interactions | Schizophrenia - physiopathology | Reaction Time - drug effects | Mice | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Central Nervous System Stimulants - administration & dosage | Excitatory Amino Acid Antagonists - adverse effects | Haloperidol - pharmacology | Disease Models, Animal | Index Medicus
Neurology | NMDA | electroencephalography | frequency oscillations | animal model | RAT | PREPULSE INHIBITION | NETWORKS | GAMMA-OSCILLATIONS | NEUROSCIENCES | MISMATCH NEGATIVITY | KETAMINE | IN-VITRO | AUDITORY-EVOKED POTENTIALS | DOPAMINE | ACOUSTIC STARTLE | Schizophrenia - chemically induced | Evoked Potentials, Auditory - drug effects | Mice, Inbred C57BL | Risperidone - pharmacology | Amphetamine - administration & dosage | Male | Electroencephalography | Biological Clocks - drug effects | Acoustic Stimulation - methods | Ketamine - adverse effects | Animals | Drug Interactions | Schizophrenia - physiopathology | Reaction Time - drug effects | Mice | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Central Nervous System Stimulants - administration & dosage | Excitatory Amino Acid Antagonists - adverse effects | Haloperidol - pharmacology | Disease Models, Animal | Index Medicus
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 09/2016, Volume 148, pp. 38 - 45
Acute exposure to ± 3,4-methylenedioxymethamphetamine (MDMA) preferentially increases release of serotonin (5-HT), and a role of 5-HT in many of the behavioral...
Self-administration | Hyperactivity | Serotonin receptors | Reinstatement | MDMA | FREELY MOVING RATS | ECSTASY DEPENDENCE | COCAINE-SEEKING BEHAVIOR | 5-HT2C RECEPTORS | RHESUS-MONKEYS | CUE-INDUCED REINSTATEMENT | LOCOMOTOR-ACTIVITY | NEUROSCIENCES | RECEPTOR ANTAGONIST | 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | Ketanserin - pharmacology | N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage | Rats | Male | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Serotonin Antagonists - pharmacology | Piperazines - pharmacology | Rats, Sprague-Dawley | Drug-Seeking Behavior - drug effects | Self Administration | Animals | Extinction, Psychological | Oxadiazoles - pharmacology | Pyridines - pharmacology | Phenols | Central nervous system agents | Ecstasy (Drug) | Resveratrol | Cocaine
Self-administration | Hyperactivity | Serotonin receptors | Reinstatement | MDMA | FREELY MOVING RATS | ECSTASY DEPENDENCE | COCAINE-SEEKING BEHAVIOR | 5-HT2C RECEPTORS | RHESUS-MONKEYS | CUE-INDUCED REINSTATEMENT | LOCOMOTOR-ACTIVITY | NEUROSCIENCES | RECEPTOR ANTAGONIST | 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | Ketanserin - pharmacology | N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage | Rats | Male | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Serotonin Antagonists - pharmacology | Piperazines - pharmacology | Rats, Sprague-Dawley | Drug-Seeking Behavior - drug effects | Self Administration | Animals | Extinction, Psychological | Oxadiazoles - pharmacology | Pyridines - pharmacology | Phenols | Central nervous system agents | Ecstasy (Drug) | Resveratrol | Cocaine
Journal Article
SCHIZOPHRENIA BULLETIN, ISSN 0586-7614, 09/2012, Volume 38, Issue 5, pp. 942 - 949
Here, we describe our collaborative efforts to use N-methyl-D-aspartate (NMDA) receptor antagonists as a translational tool to advance our understanding of the...
PSYCHIATRY | GLUTAMATERGIC DYSFUNCTION | RATS | SCHIZOPHRENIA | PREFRONTAL CORTEX | PHENCYCLIDINE | ketamine | SUBANESTHETIC KETAMINE | NMDA | DOPAMINE | HEALTHY-VOLUNTEERS | AMPHETAMINE | glutamate | WORKING-MEMORY | Receptors, Metabotropic Glutamate - drug effects | Phencyclidine - pharmacology | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Neurosciences | Humans | Receptors, Metabotropic Glutamate - physiology | Emotions - drug effects | Cerebral Cortex - physiopathology | Allosteric Regulation - physiology | Psychoses, Substance-Induced - physiopathology | Antipsychotic Agents - therapeutic use | Schizophrenia - physiopathology | Receptors, Dopamine D2 - drug effects | Receptor, Metabotropic Glutamate 5 | Cerebral Cortex - drug effects | Dopamine - metabolism | Disease Models, Animal | Allosteric Regulation - drug effects | Emotions - physiology | Phencyclidine - antagonists & inhibitors | Synapses - drug effects | Synapses - physiology | Translational Medical Research | Glutamic Acid - physiology | Receptors, N-Methyl-D-Aspartate - physiology | Brief Psychiatric Rating Scale | Animals | Receptors, Dopamine D2 - physiology | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Ketamine - pharmacology
PSYCHIATRY | GLUTAMATERGIC DYSFUNCTION | RATS | SCHIZOPHRENIA | PREFRONTAL CORTEX | PHENCYCLIDINE | ketamine | SUBANESTHETIC KETAMINE | NMDA | DOPAMINE | HEALTHY-VOLUNTEERS | AMPHETAMINE | glutamate | WORKING-MEMORY | Receptors, Metabotropic Glutamate - drug effects | Phencyclidine - pharmacology | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Neurosciences | Humans | Receptors, Metabotropic Glutamate - physiology | Emotions - drug effects | Cerebral Cortex - physiopathology | Allosteric Regulation - physiology | Psychoses, Substance-Induced - physiopathology | Antipsychotic Agents - therapeutic use | Schizophrenia - physiopathology | Receptors, Dopamine D2 - drug effects | Receptor, Metabotropic Glutamate 5 | Cerebral Cortex - drug effects | Dopamine - metabolism | Disease Models, Animal | Allosteric Regulation - drug effects | Emotions - physiology | Phencyclidine - antagonists & inhibitors | Synapses - drug effects | Synapses - physiology | Translational Medical Research | Glutamic Acid - physiology | Receptors, N-Methyl-D-Aspartate - physiology | Brief Psychiatric Rating Scale | Animals | Receptors, Dopamine D2 - physiology | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Ketamine - pharmacology
Journal Article
Psychopharmacology, ISSN 0033-3158, 7/2019, Volume 236, Issue 7, pp. 2243 - 2258
Methamphetamine (MA) is an abused psychostimulant that causes cognitive deficits after chronic use. Neostriatal dopamine receptors play a role in MA monoamine...
Dopamine D2 antagonist | Neurosciences | Rat | Methamphetamine | Dopamine D1 antagonist | Sulpiride | Monoamines | Spatial learning | Biomedicine | SCH-23390 | Egocentric learning | Pharmacology/Toxicology | Psychiatry | CAUDATE-PUTAMEN | PSYCHIATRY | MORRIS WATER MAZE | PATH-INTEGRATION | NEUROSCIENCES | NUCLEUS-ACCUMBENS | COGNITIVE IMPAIRMENTS | DOUBLE DISSOCIATION | STRIATAL DOPAMINE | TRANSPORTER FUNCTION | PHARMACOLOGY & PHARMACY | INDUCED NEUROTOXICITY | RECEPTORS | Animal experimentation | Phenols | Dopamine receptors | Water treatment | Drug abuse | Spatial discrimination learning | Cognitive ability | Activation | Antagonists | Navigation behavior | Learning | Neurotoxicity | Receptors | Methamphetamines | Rodents | Neostriatum | Attenuation | Pretreatment | Dopamine D2 receptors | Dopamine | Serotonin | Animal memory | Maze learning | Gliosis | Dopamine D1 receptors | Spatial memory
Dopamine D2 antagonist | Neurosciences | Rat | Methamphetamine | Dopamine D1 antagonist | Sulpiride | Monoamines | Spatial learning | Biomedicine | SCH-23390 | Egocentric learning | Pharmacology/Toxicology | Psychiatry | CAUDATE-PUTAMEN | PSYCHIATRY | MORRIS WATER MAZE | PATH-INTEGRATION | NEUROSCIENCES | NUCLEUS-ACCUMBENS | COGNITIVE IMPAIRMENTS | DOUBLE DISSOCIATION | STRIATAL DOPAMINE | TRANSPORTER FUNCTION | PHARMACOLOGY & PHARMACY | INDUCED NEUROTOXICITY | RECEPTORS | Animal experimentation | Phenols | Dopamine receptors | Water treatment | Drug abuse | Spatial discrimination learning | Cognitive ability | Activation | Antagonists | Navigation behavior | Learning | Neurotoxicity | Receptors | Methamphetamines | Rodents | Neostriatum | Attenuation | Pretreatment | Dopamine D2 receptors | Dopamine | Serotonin | Animal memory | Maze learning | Gliosis | Dopamine D1 receptors | Spatial memory
Journal Article